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Objective: To investigate relationship between serum hyaluronan (HA) level and the presence and
severity of radiographic knee osteoarthritis (OA) as well as degree of knee pain in Japanese population.
Design: A total of 616 volunteers participated in this study. Based on the KellgreneLawrence (KeL) grade,
participants were radiographically classiﬁed into three groups: Normal (KeL grade 0 or 1), Moderate
(grade 2) and Severe (grade 3 or 4). The degree of knee pain was quantiﬁed by visual analogue scale
(VAS) and Knee injury and Osteoarthritis Outcome Score (KOOS) Pain. Serum HA levels were compared
among the Normal, Moderate and Severe groups, and the relationship between serum HA level and the
severity of knee OA was analyzed after age, sex and body mass index (BMI) were adjusted. In addition,
the correlation between serum HA level and the degree of knee pain was analyzed in each group.
Results: Regarding relationship between serum HA level and the severity of radiographic knee OA, serum
HA levels of the Moderate and Severe groups were signiﬁcantly higher than in the Normal group
(P< 0.001). Furthermore, serum HA level correlated with the severity of radiographic knee OA (r¼ 0.289,
P< 0.001) after adjusting for age, sex and BMI. Serum HA level correlated with VAS of knee pain and/or
KOOS Pain in the Normal and Moderate groups.
Conclusion: Serum HA level has the potential to be useful for the diagnosis of the presence and severity of
knee OA.
 2010 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Knee Osteoarthritis (OA) is one of the most common knee joint
diseases in the elderly, and is characterized by progressive cartilage
degradation and concomitant bony hypertrophy. In clinical prac-
tice, diagnosis and assessment of knee OA are conventionally based
on clinical history and radiological ﬁndings1,2. Patients’ chief
complaints are pain and stiffness of their knees, and radiological
ﬁndings of knee OA include joint space narrowing, osteophyte
formation, subchondral sclerosis and cysts3. However, radiological
ﬁndings don’t always reﬂect patients’ knee symptoms. Recently,
several alternative techniques have been used to assess knee OA,
especially in its early stages. Magnetic resonance imaging (MRI) is
a useful technique for assessing cartilage lesions of knee OA4,5. In
addition, ultrasonography is also used to assess cartilage lesions6.: Ryo Inoue, Department of
ool of Medicine, 5 Zaifu-cho,
83; Fax: 81-172-36-3826.
. Inoue).
s Research Society International. PTo date, various biomarkers of knee OA have been studied to
potentially aid in early diagnosis and to assess minor changes in
patients’ bone or cartilage that are predictive factors for further
development of knee OA7e11. Cibere et al. reported that serum and
urinary biomarkers of pre-radiographically deﬁned OA12. They
suggested that speciﬁc biomarker ratios combining cartilage
degradation markers and synthesis markers were better able to
differentiate OA stages compared with individual marker levels.
Early diagnosis and prediction of progression are of particular
importance from the standpoint of prevention and therapeutic
strategy. However, although several biomarkers for knee OA have
been investigated, there is no established marker for pre-radio-
graphic knee OA.
Hyaluronan (HA) is a high molecular weight glycosaminoglycan,
composed of alternating subunits of glucosamine and glucuronic
acid. It has been reported to be widely distributed in much of
extracellular matrix (ECM). HA is produced locally by cells of the
ECM, and it plays a role in structural properties as well as in cell
signaling13. HA and HA fragments were released into the systemic
circulation by degeneration and turnover of the ECM14. HA isublished by Elsevier Ltd. All rights reserved.
Table I
Age, BMI, degree of knee pain, serum HA level and KeL grade of radiographic knee
OA in study participants
Age, BMI, degree of knee pain and serum HA level
Male (n¼ 242) Female (n¼ 374) P-value
Age (year) 57.0 12.4 58.5 10.4 0.139
BMI (kg/m2) 23.4 2.7 22.8 3.2 <0.001*
VAS of knee pain (mm) 9.0 15.4 12.3 19.9 0.063
KOOS Pain (point) 93.9 12.0 91.1 13.5 <0.001*
Serum HA level (ng/ml) 61.9 35.9 65.0 38.0 0.329
KeL grade and the prevalence rate of radiographic knee OA
Male (n¼ 242) Female (n¼ 374) P-value
KeL grading Grade 0 90 62
Grade 1 114 173
Grade 2 34 104
Grade 3 3 32
Grade 4 1 3
Severity Normal group 204 (84.3%) 235 (62.8%)
Moderate group 34 (14.0%) 104 (27.8%)
Severe group 4 (1.7%) 35 (9.4%)
Laterality Unilateral group 11 (4.5%) 47 (12.6%)
Bilateral group 27 (11.2%) 92 (24.6%)
Prevalence rate 38 (15.7%) 139 (37.2%) P< 0.001#
The values of Age, BMI, VAS of knee pain, KOOS Pain and serum HA level are the
mean S.D. P-values below 0.05* indicate a signiﬁcant level of difference between
male and female, using ManneWhitney U test. By the severity of the participants’
worse knee, they were classiﬁed into three groups: Normal (KeL grade of 0 or 1),
Moderate (KeL grade of 2) and Severe (KeL grade of 3 or 4). By the laterality of
radiographic knee OA, theywere classiﬁed into three groups: Normal, Unilateral and
Bilateral. The presence of radiographic knee OA was deﬁned as a KeL grade of 2, 3
and 4. P-values below 0.05# indicate a signiﬁcant level of association between the
prevalence rate of radiographic knee OA and sex, using c2 test.
Table II
Numbers of knees, hips and hands with radiographic OA, and correlationwith serum
HA level
Numbers of joints with radiographic OA
Knee OA Hip OA Hand OA
Normal 439 Normal 512 0e2 joints 568
Unilateral 58 Unilateral 65 3e6 joints 33
Bilateral 119 Bilateral 39 7e0 joints 15
Correlation between serum HA level and numbers of joints with OA
Unadjusted Age, Sex and BMI adjusted
r P-value r P-value
Knee OA 0.395 <0.001* Knee OA 0.220 <0.001*
Hip OA 0.108 0.007* Hip OA 0.065 0.109
Hand OA 0.262 <0.001* Hand OA 0.213 <0.001*
r¼ correlation coefﬁcient. The numbers of knees and hips with OA are represented
as 0e2 joints. Scores of Hand OA are represented as 0 (0e2 hand joints affected), 1
(3e6) and 2 (7-). The relationship between serum HA level and the numbers of knee
and hip OA joints, scores of hand OA were analyzed by Spearman rank correlation
coefﬁcient (unadjusted) and partial correlation analysis (age, sex and BMI adjusted).
P-values below 0.05* indicate a signiﬁcant level.
R. Inoue et al. / Osteoarthritis and Cartilage 19 (2011) 51e5752present in high concentrations in joint tissues including synovium,
cartilage, and synovial ﬂuid. Recently, increase in serum level of HA
has been suggested as a result of synovial inﬂammation and
cartilage degradation, and thus, the measurement of the HA level in
serum may be useful in assessing knee OA activity as well as
determining predictive factors15,16.
In previous studies, it has been reported that serum HA level
was associated with the presence of radiographic knee OA17e20.
However, radiographic knee OA indicates the stable structural
condition of this disease rather than the activity of the disease at
the time. The objectives of this study were to investigate the rela-
tionship between serum HA level and the degree of knee pain as
well as the presence and severity of radiographic knee OA.
Methods
Participants
The Iwaki Health Promotion Project is a community-based
program to increase average life expectancy by performing general
health checkups. This program began in 2005 and is being con-
ducted over a 10-year-period. About 1000 people who are 20 years
or older living in the Iwaki area of Hirosaki city located west of
Aomori, Japan participate every year. Physicians, surgeons, ortho-
pedists, gynecologists, urologists, psychiatrists, dermatologists and
dentists from Hirosaki University are involved in this project to
investigate diseases and disorders in various ﬁelds. The research of
risk factors and prevention for knee OA is one part of this project.
A total of 886 volunteers (20e86 years old, 325 males and 561
females) participated in the Iwaki Health Promotion Project in 2008.
Exclusion criteria for our studywere history of rheumatoid arthritis,
hepatic disease, renal disease or malignant disease, total knee
arthroplasty, total hip arthroplasty and femoral head replacement.
In addition, knee OA patients under treatment and those taking oral
nonsteroidal anti-inﬂammatory drugs (NSAIDs)were also excluded.
Finally, 616 participants (242males and 374 females) were included
in this study. The mean (SD) ages in male and female participants
were 57.012.4 (range: 27e85) and 58.510.4 (21e80) years, and
there were no differences between male and female (P¼ 0.139)
(Table I). Approval for the study was obtained from the Ethics
Committee of Hirosaki University School of Medicine and all
subjects gave written informed consent before participating.
All participants answered questionnaires about their medical
history, lifestyle, smoking, drinking, and ﬁtness habits, occupa-
tional history, family history, health-related quality of life, various
disease-speciﬁc information including knee symptoms and intake
of supplements for the knee. Anthropometric measurement
included height, weight, body mass index (BMI), body fat
percentage, density of bone, waist-hip ratio, bilateral grip strength,
functional reach test21,22, and timed up and go (TUG) test23,24. TUG
test was performed to evaluate ability to rise from a seated position,
walk 3 m, turn, and walk back returning to a seated position.
Blood and urine samples were taken in all participants before
breakfast in the early morning for biochemical examinations. The
serum HA level was determined using the Hyaluronan Assay Kit
(Seikagaku Corporation, Tokyo, Japan). In clinical examination by
well-experienced orthopedists, information about the knee, hip,
elbow, neck and low back including range of motion was taken.
Plain radiographs of knee, hip, hand, cervical spine and lumber
spine were taken for 817 out of 886 participants.
Knee symptoms
To evaluate degree of knee pain, visual analogue scale (VAS) in
both knees and Knee Injury and Osteoarthritis Outcome Score(KOOS) subscale Pain were used. In VAS evaluation, the degree of
knee pain for the last week was quantiﬁed on a scale of 0e100 mm,
and VAS score of asymptomatic knees were evaluated for 0 mm. In
analysis, the mean values of VAS in both knees were used.
KOOS is a 42-item knee-speciﬁc self-administered instrument
with ﬁve subscales: Pain, Symptom, Activities of Daily Living (ADL),
Sport and Recreation (Sport/Rec) and Knee-related Quality of Life
(QOL). All items were scored from 0 to 4 and summed. Raw scores
were then transformed to a 0e100 scale where 100 represents the
best result. A separate score was calculated for each of the ﬁve
subscales25. KOOS Pain was calculated by 9 out of the 42 items.
However, there is no Japanese version of KOOS at the present.
Therefore, two orthopedists independently of each other translated
Table III
Comparison of serumHA level among age-groups and between Normal and knee OA
participants in each age-group
Normal (n) Knee OA (n)
20 s 32.3 9.0 (5) e (0)
30 s 35.1 8.4 (24) 27.1 (1)
40 s 38.1 8.5 (111) 46.1 10.5* (5)
50 s 52.9 23.5y,z (156) 61.5 27.0 (37)
60 s 68.5 29.6*,y,z,x (96) 79.4 41.0 (76)
70 s 79.2 31.0*,y,z,x (44) 114.8 49.9#,yy,zz* (52)
80 s 127.0 53.8*,y,z,x,k,{ (3) 138.6 53.9#,yy,zz (6)
Values of serum HA level are the mean S.D (ng/ml). Comparisons of serum HA
level among age-groups (20 s, 30 s, 40 s, 50 s, 60 s, 70 s and 80 s) and between
Normal and knee OA participants in each age-group were analyzed using two-way
ANOVA. Tukey’s test was performed among age-groups and ManneWhitney U test
was performed between Normal and knee OA participants for post hoc analysis.
P-value below 0.05 *ezz, * indicates signiﬁcance level.
* P< 0.05 between Normal and Knee OA.
* P< 0.05 vs Normal in 20 s.
y P< 0.05 vs Normal in 30 s.
z P< 0.05 vs Normal in 40 s.
x P< 0.05 vs Normal in 50 s.
k P< 0.05 vs Normal in 60 s.
{ P< 0.05 vs Normal in 70 s.
# P< 0.05 vs Knee OA in 40 s.
yy P< 0.05 vs Knee OA in 50 s.
zz P< 0.05 vs Knee OA in 60 s.
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orthopedists had a medical background in knee disease and both
were native Japanese speakers. Secondly, two bilingual persons
who were blinded to the original English version re-translated
independently of each other this Japanese version into English26.
Finally, all translators had a consensus meeting to consolidate the
ﬁnal Japanese translation of the KOOS questionnaire, which was
used.Radiographic knee, hip and hand OA
On the day of general health checkups, weight-bearing and
anterioreposterior radiographs of both knees and hips and dorsal-
volar hands of participants were taken. Scores were given to each
knee and hip radiograph based on the KellgreneLawrence (KeL)
grade of either 0,1, 2, 3 or 43. The presence of radiographic knee and
hip OA were deﬁned as a KeL grade of 2, 3 and 4 and participants
were classiﬁed into Normal (0 affected), Unilateral (1 affected) and
Bilateral (2 affected) knee and/or hip OA by the laterality, respec-
tively. For hand OA, a sum score was derived based on the number
of joint sites with KeL grades of 2, 3 and 4. The sum score of the
hand ranged from 0 to 20, consisting of the distal interphalangeal
joint (DIP) 2e5, proximal interphalangeal joint (PIP) 2e5, inter-
phalangeal joint 1, and carpometacarpal joint 1. The hand OA score
(0e2) represents participants with, respectively, 0e2, 3e6, and
7-hand joints affected27. By the severity of radiographic knee OA in
the participants’worse knee, theywere classiﬁed into three groups:
Normal (KeL grade of 0 or 1), Moderate (KeL grade of 2) and Severe
(KeL grade of 3 or 4). Although lateral radiographs were taken of
the cervical and lumber spines, it was hard to deﬁne spine OA
because the lumber facet joint OA could not be evaluated, and C5/6
and C6/7 of some participants were invisible. Only radiographs of
knees, hips and hands were used in this study.Fitness, smoking and drinking habits
Regarding ﬁtness habits, participants who exercise once ormore
aweekwere included in the ﬁtness habit group. Regarding smoking
and drinking, only participants who had habits at the present timewere included in the habit group, and those who had habits in the
past were included in the non-habit group.
Statistical analysis
Data input and calculation were performed with the SPSS
ver.12.0J (SPSS Inc., Chicago, IL, USA). The comparison of age, BMI,
VAS of knee pain, KOOS Pain and serumHA level betweenmale and
female were performed using ManneWhitney U test. The preva-
lence rate of radiographic knee OA between male and female was
analyzed using c2 test. The relationship between serum HA level
and the number of knee and hip OA joints, and score of hand OA
were analyzed by Spearman rank correlation coefﬁcient, and partial
correlation analysis to adjust age, sex and BMI. One-way analysis of
variance (ANOVA) was used to analyze age, BMI, VAS of knee pain,
KOOS Pain and serum HA level among Normal, Moderate and
Severe groups, and Tukey’s test for post hoc analysis was performed.
Comparisons of serum HA level among age-groups (20 s, 30 s, 40 s,
50 s, 60 s, 70 s and 80 s) and between Normal and knee OA partic-
ipants in each age group were analyzed using two-way ANOVA.
Tukey’s test was performed to compare serum HA level among age-
groups andManneWhitney U test was performed between Normal
and knee OA participants for post hoc analysis. The relationship
between serum HA level and the severity of radiographic knee OA
was analyzed by Spearman rank correlation coefﬁcient, and partial
correlation analysis to adjust age, sex and BMI. In addition, to
evaluate the relationship between serum HA level and the degree
of knee pain, the relationships between serum HA level and VAS of
knee pain and/or KOOS Pain were analyzed by Spearman rank
correlation coefﬁcient. Furthermore, multiple regression analysis
was performed with serum HA level as the independent variable,
and VAS of knee pain, age, sex, BMI, laterality of radiographic knee
OA, intake of supplements for knee, ﬁtness, smoking and drinking
habits as the dependent variables in the Normal, Moderate and
Severe groups, respectively. In addition, KOOS Pain was substituted
for VAS of knee pain as the independent variable in the same way.
In all analysis, P-values< 0.05 were considered signiﬁcant.
Results
Regarding the severity of radiographic knee OA, 204 (84.3%) out
of 242 males were classiﬁed as Normal, 34 (14.0%) as Moderate and
4 (1.7%) as Severe, and 235 (62.8%) out of 374 females were clas-
siﬁed as Normal, 104 (27.8%) as Moderate and 35 (9.4%) as Severe
(Table I). The prevalence rates of radiographic knee OA were 15.7%
(Unilateral: 4.5%, Bilateral: 11.2%) in males and 37.2% (Unilateral:
12.6%, Bilateral: 24.6%) in females. The prevalence rate of radio-
graphic knee OA was signiﬁcantly higher in females than in males
(P< 0.001) (Table I). Characteristically, in both males and females,
the Moderate (both male and female: P< 0.001) and Severe (male:
P¼ 0.017, female: P< 0.001) groups were signiﬁcantly older than
the Normal groups. There were no signiﬁcant differences in BMI
among the three groups in males. However, that of the Moderate
(P¼ 0.022) and Severe (P< 0.001) groups in females were signiﬁ-
cantly higher than the Normal group (Table IV).
Regarding the degree of knee pain, the mean values of VAS of
knee pain in males and females were 9.015.4 and 12.319.9,
respectively, and there was no signiﬁcant difference betweenmales
and females (P¼ 0.063) (Table I). Regarding the relationship
between VAS of knee pain and the severity of radiographic knee OA,
the mean values of VAS of knee pain of the Moderate (male:
P¼ 0.049, female: P¼ 0.002) and Severe (both male and female:
P< 0.001) groups were signiﬁcantly higher than the Normal group
(Table IV). Themean values of KOOS Pain inmales and females were
93.912.0 and 91.113.5, and that of females was signiﬁcantly
Table IV
Relationship between serum HA level and severity of radiographic knee OA
Normal Moderate P-value Severe P-value
Male Age (year) 55.2 11.9 66.4 10.6 <0.001* 71.5 7.9 0.017*
BMI (kg/m2) 23.4 2.7 23.3 2.4 0.967 23.8 2.7 0.951
VAS of knee
pain (mm)
7.5 13.4 13.9 17.5 0.049* 45.8 37.6 <0.001*
KOOS Pain 95.6 8.6 87.3 16.9 <0.001* 62.5 37.9 <0.001*
Serum HA
level (ng/ml)
55.2 27.6 90.2 38.9 <0.001* 166.1 94.9 <0.001*
Female Age (year) 54.8 10.0 63.7 7.9 <0.001* 68.2 6.3 <0.001*
BMI (kg/m2) 22.2 2.7 23.2 3.5 0.022* 25.1 4.0 <0.001*
VAS of knee
pain (mm)
8.1 15.2 15.8 22.7 0.002* 30.2 26.4 <0.001*
KOOS Pain 95.1 9.0 87.4 15.3 <0.001* 75.0 17.5 <0.001*
Serum HA
level (ng/ml)
53.9 27.3 72.4 36.4 <0.001* 117.4 53.6 <0.001*
Correlation between serum HA level and severity of radiographic knee OA
Unadjusted Age, Sex and BMI adjusted
r P-value r P-value
Severity of Knee OA 0.410 <0.001# Severity of Knee OA 0.289 <0.001#
The values of Age, BMI, VAS of knee pain, KOOS Pain and serum HA level are the
mean S.D. P-value below 0.05* indicates signiﬁcant difference from Normal.
r¼ correlation coefﬁcient. P-values below 0.05# indicate a signiﬁcant level by
Spearman rank correlation coefﬁcient (unadjusted) and partial correlation analysis
(Age, Sex and BMI adjusted).
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KOOS Pain and the severity of radiographic knee OA, the mean
values of KOOS Pain of the Moderate and Severe groups in both
males and females were signiﬁcantly lower than in the Normal
groups (P< 0.001, respectively) (Table IV).
Serum HA level correlated with aging (r¼ 0.676, r< 0.001) and
the number of knee OA (r¼ 0.395, r< 0.001) and hip OA (r¼ 0.108,
P¼ 0.007) joints and/or the scores of hand OA (r¼ 0.262, r< 0.001).
In addition, it correlated with the number of knee OA (r¼ 0.220,
P< 0.001) joints and the score of hand OA (r¼ 0.213, r< 0.001) after
age, sex and BMI were adjusted (Table II). The mean values (SD) of
serum HA levels in males and females were 61.9 35.9 and
65.0 38.0 ng/ml respectively, and there was no signiﬁcant differ-
ence between males and females (P¼ 0.329) (Table I). In addition,
the mean values in males and females were 55.2 27.6 and
53.9 27.3 ng/ml in Normal, 90.2 38.9 and 72.4 36.4 ng/ml in
Moderate, 166.194.9 and 117.4 53.6 ng/ml in Severe group,
respectively. The mean values of serum HA levels of the Moderate
and Severe groupswere signiﬁcantly higher than theNormal groups
in both males and females (P< 0.001, respectively) (Table IV).
Regarding comparison of serum HA levels in each age group, serum
HA levels gradually increased with aging. Furthermore, serum HA
levels of the knee OA group in the 40 s (P¼ 0.048) and 70 s
(P< 0.001) were signiﬁcantly higher than in the Normal group
(Table III).
Regarding the relationship between serum HA level and the
severity of radiographic knee OA, serum HA level correlated with
the severity of radiographic knee OA (r¼ 0.410, r< 0.001), and it
also correlated with that (r¼ 0.289, P< 0.001) after age, sex and
BMI were adjusted (Table IV). Regarding the relationship between
serum HA level and the degree of knee pain in each group by the
severity of radiographic knee OA, signiﬁcant correlation between
serum HA level and VAS of knee pain was seen in the Total
(r¼ 0.199, P< 0.001) and the Moderate (r¼ 0.177, P¼ 0.037)
groups, and signiﬁcant correlation between serum HA level and
KOOS Pain was seen in the Total (r¼0.255, P< 0.001) and the
Moderate (r¼0.252, P¼ 0.003) groups (Table V). After age, sex,
BMI, laterality of radiographic knee OA, intake of supplements for
the knee, ﬁtness, smoking and drinking habits were adjusted,signiﬁcant correlation between serum HA level and VAS of knee
pain was seen in the Normal (P¼ 0.002) and Moderate (P¼ 0.003)
groups, in the same way, signiﬁcant correlation between serum HA
level and KOOS Pain was seen in the Normal (P< 0.001) and
Moderate (P< 0.001) groups (Table V). As for the remainder, posi-
tive correlation between serum HA level and age was seen in the
Normal and Moderate groups (P< 0.001, respectively). However,
there were no correlations between serum HA level and VAS of
knee pain (P¼ 0.460), KOOS Pain (P¼ 0.077) or age (P¼ 0.051 with
VAS of knee pain, P¼ 0.075 with KOOS Pain) in the Severe group in
the same analysis (Table V).
Discussion
This study showed that serumHA level was positively associated
with the occurrence of radiographic knee OA, and with the degree
of knee pain in the Normal and Moderate knee OA groups. In
several previous studies, relationships between serumHA level and
radiographic knee OA have been investigated by various methods.
Elliott et al. reported that serum HA level was positively associated
with the presence and severity of radiographic knee OA in their
large-scale study19. George and Pavelka reported that serum HA
level had a predictive value for further development of knee OA17,18.
On the other hand, Turan et al. reported that serum HA level of
patients in a knee OA groupwas signiﬁcantly higher than that of the
normal healthy control group. However, they reported that there
was no signiﬁcant difference in serum HA levels between groups
with KeL grade 2 and KeL grade 3e415. In this study, signiﬁcant
differences of serum HA level were seen not only among Normal,
Unilateral and Bilateral groups but also among Normal, Moderate
and Severe groups by radiographic knee OA after age, sex and BMI
were adjusted. Our study suggested that the presence and severity
of radiographic knee OA caused an increase in serum HA level as in
the large-scale study by Elliott et al. Regarding correlation between
serum HA level and the number of OA joints, serum HA level was
correlated with the number of knee and hip OA joints and the score
of hand OA, respectively. Kraus et al. reported that serum HA level
correlated with the joints affected by osteophytes in hands, hips,
knees and lumber spine28. In this study, by Spearman rank corre-
lation coefﬁcient, serum HA level was more closely-linked to knee
OA (r¼ 0.395) than hip (r¼ 0.108) or hand OA (r¼ 0.262). These
results suggested that knee OA joints were more closely associated
with serum HA level increase.
In relationship between serum HA level and the degree of knee
pain in each group by the severity of radiographic knee OA, serum
HA level was positively correlated with VAS of knee pain and KOOS
Pain in Normal and Moderate groups in this study. Because the
degree of knee pain seems to reﬂect synovial inﬂammation29 and
cartilage degeneration at the time30, these positive correlations
suggest that measurement of serum HA level is useful as
a biomarker in moderate stage of knee OA. In addition, the knee
pain can be objectively evaluated by measuring serum HA level in
normal or moderate OA patients. On the other hand, there was no
correlation between serum HA level and VAS of knee pain and
KOOS Pain in the Severe group. In those results, the baseline of
serum HA level in the Severe group was very high and correlation
was not observed. High level of serum HA may reﬂect not only
a high degree of knee pain but also the severity of radiographic
knee OA. Therefore, it is suggested that the serum HA level is not
suitable as a pain biomarker in severe radiographic knee OA
patients. Turan et al. reported that there was no signiﬁcant corre-
lation between serum HA level of a knee OA group and Western
Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
Pain score15. As for the reason, their analysis was a simple corre-
lation coefﬁcient between serum HA level and WOMAC Pain score
Table V
Relationship between serum HA level and the degree of knee pain (VAS, KOOS Pain)
Correlation between serum HA level and Age, VAS of knee pain and KOOS Pain
Age VAS of knee pain KOOS Pain
r P-value r P-value r P-value
Serum HA level in Normal 0.642 <0.001* 0.069 0.149 0.087 0.067
Serum HA level in Moderate 0.550 <0.001* 0.177 0.037* 0.252 0.003*
Serum HA level in Severe 0.218 0.183 0.086 0.604 0.293 0.070
Serum HA level in Total 0.676 <0.001* 0.199 <0.001* 0.255 <0.001*
Relationship between serum HA level and Age, VAS of knee pain and KOOS Pain in Normal, Moderate and Severe Knee OA groups (some factors adjusted)
B 95%CI P-value
Serum HA level in Normal VAS 0.236 0.085 e 0.387 0.002#
Age 1.369 1.162 e 1.577 <0.001#
KOOS Pain 0.264 -0.520 e 0.007 0.044#
Age 1.350 1.142 e 1.559 <0.001#
Serum HA level in Moderate VAS 0.391 0.138 e 0.645 0.003#
Age 2.299 1.662 e 2.935 <0.001#
KOOS Pain 0.625 0.965 e 0.286 <0.001#
Age 2.280 1.653 e 2.907 <0.001#
Serum HA level in Severe VAS 0.264 0.455 e 0.982 0.460
Age 3.148 0.009 e 6.304 0.051
KOOS Pain 0.945 1.998 e 0.107 0.077
Age 2.738 0.290 e 5.766 0.075
r¼ correlation coefﬁcient. The relationships between serum HA level and Age, VAS of knee pain and/or KOOS Pain in Normal, Moderate and Severe knee OA groups and Total
participants were analyzed by Spearman rank correlation coefﬁcient. P-values below 0.05* indicate a signiﬁcant level. Multiple regression analysis was performed with serum
HA level as the independent variable, and VAS of knee pain or KOOS Pain, age, sex, BMI, laterality of radiographic knee OA, intake of supplements for knee, ﬁtness, smoking and
drinking habits as the dependent variables in the normal, moderate and severe groups, respectively. P-values below 0.05# indicate a signiﬁcant level of correlation with serum
HA level. B: regression coefﬁcients, 95%CI: 95% conﬁdence intervals.
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knee OA, in contrast to this study. Furthermore, VAS of knee pain
and KOOS Pain were used to evaluate degree of knee pain in this
study.
To provide more accurate evaluation of degree of knee pain and
serum HA level, many participants were excluded from this study.
Firstly, to evaluate the degree of knee pain more accurately,
patients currently under knee OA treatment and participants taking
oral NSAIDs were excluded. Although several previous studies of
knee OA biomarkers included patients under treatment31,32, we
cannot completely assess details of treatments because they
include oral medicine, external medicine and joint injections.
Furthermore, patients with diseases of elevated serum HA level
were also excluded at the beginning of this study, so that factors
which inﬂuence serum HA level could be evaluated more accu-
rately. It has been reported that HA enters the circulation as a result
of synovial inﬂammation and cartilage degeneration, and serumHA
level can be increased in RA patients33,34. In addition, because HA is
widely distributed in the whole body, serum HA levels have been
shown to be increased in patients with hepatic disease35,36, renal
disease37 and malignant disease38,39.
Regarding the relationship between serum HA level and aging,
this study clearly showed that serum HA levels increased with age.
SerumHA levels of participants in their 50 s, 60 s, 70 s and 80 swere
signiﬁcantly higher than in the younger groups. This result was
similar to the previous studies showing that levels in those 50 years
or older were signiﬁcantly higher than in younger subjects40. In
addition, after adjustment for several factors including the pres-
ence of radiographic knee OA, the serum HA levels were positively
correlated with aging in this study. Therefore, when serumHA level
is evaluated, effects produced by aging always have to be adjusted.
Furthermore, important consideration in the evaluation of the age
related increase in serum HA level is that it may be due to OA in
other joints and spine. In previous studies, it has been shown that
serum HA level was inﬂuenced by various factors other than the
diseases described above. For example, activity level, eatings andintake of supplements for the knee were reported to increase
serum HA level31,41e43. In this study, all blood samples of partici-
pants were taken before breakfast in the early morning, and the
inﬂuence of activity and intake of supplements for the knee was
statistically adjusted.
There were several limitations in this study. One was that it was
performed in a limited region, which may not be representative of
Japan as a whole. Because this study was to investigate the data of
the general population, there was little data of knee OA patients,
especially KeL grade 3 or 444,45. This may have caused the lack of
correlation between serum HA level and degree of knee pain in the
Severe group. The KOOS instrument translated to Japanese that we
used has not yet been validated in detail, and psychometric prop-
erties were invalid46,47. However, evaluation by KOOS Pain played
much the same role as VAS of knee pain in this study. Inﬂammatory
indexes, such as erythrocyte sedimentation rate (ESR) or high-
sensitive C-reactive protein, were not measured in this study.
Although VAS of knee pain and KOOS Pain were taken as degree of
synovial inﬂammation and/or cartilage degeneration, there was no
objective evidence. Finally, analyses in this study did not include
evaluation of the presence of spine OA joints, which would likely
increase serum biomarker levels27,48.
Despite these limitations, this general population-based study
clearly showed strong associations between serumHA level and the
presence and severity of radiographic knee OA. Furthermore, this is
the ﬁrst study, as far as we know, to show that serum HA level in
normal or moderate knee OA patients were positively correlated
with the degree of knee pain. Based on this result, determination of
serum HA level can be considered useful as an assessment option
for OA knee pain, especially for evaluation of moderate knee OA.
Conclusions
Serum HA level was strongly associated with the presence and
severity of radiographic knee OA. Additionally, serum HA level
correlated with the degree of knee pain in radiographically normal
R. Inoue et al. / Osteoarthritis and Cartilage 19 (2011) 51e5756and moderate knee OA patients. It is suggested that serum HA
levels have the potential to be useful for the diagnosis of the
presence and severity of knee OA.
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